BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28735069)

  • 1. Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group.
    Penel N; Le Cesne A; Bonvalot S; Giraud A; Bompas E; Rios M; Salas S; Isambert N; Boudou-Rouquette P; Honore C; Italiano A; Ray-Coquard I; Piperno-Neumann S; Gouin F; Bertucci F; Ryckewaert T; Kurtz JE; Ducimetiere F; Coindre JM; Blay JY
    Eur J Cancer; 2017 Sep; 83():125-131. PubMed ID: 28735069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Event-free survival in Desmoid-Type fibromatosis (DTF): A pre-post comparison of upfront surgery versus wait-and-see approach.
    Ruspi L; Cananzi FCM; Sicoli F; Samà L; Renne SL; Marrari A; Gennaro N; Colombo P; Cozzaglio L; Politi LS; Bertuzzi A; Quagliuolo V
    Eur J Surg Oncol; 2021 May; 47(5):1196-1200. PubMed ID: 32847695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors influencing event-free survival and treatments in desmoid-type fibromatosis: analysis from a large institution.
    Huang K; Wang CM; Chen JG; Du CY; Zhou Y; Shi YQ; Fu H
    Am J Surg; 2014 Jun; 207(6):847-54. PubMed ID: 24119719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoid fibromatosis in children and adolescents: a conservative approach to management.
    Honeyman JN; Theilen TM; Knowles MA; McGlynn MM; Hameed M; Meyers P; Crago AM; La Quaglia MP
    J Pediatr Surg; 2013 Jan; 48(1):62-6. PubMed ID: 23331794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the best front-line approach in patients with desmoid fibromatosis? - A retrospective analysis from a reference center.
    Sobczuk P; Agnieszczak IM; Grycuk W; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Morysiński T; Zdzienicki M; Rutkowski P
    Eur J Surg Oncol; 2021 Oct; 47(10):2602-2608. PubMed ID: 33994241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of young patients with desmoid-type fibromatosis: Initial surveillance does not jeopardize long term quality of life.
    Duhil de Bénazé G; Vigan M; Corradini N; Minard-Colin V; Marie-Cardine A; Verite C; Defachelles AS; Thebaud E; Castex MP; Sirvent N; Bodet D; Mansuy L; Rome A; Petit A; Plantaz D; Jourdain A; Mary P; Carton M; Orbach D
    Eur J Surg Oncol; 2020 Jul; 46(7):1294-1300. PubMed ID: 32173177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical excision versus observation as initial management of desmoid tumors: A population based study.
    Turner B; Alghamdi M; Henning JW; Kurien E; Morris D; Bouchard-Fortier A; Schiller D; Puloski S; Monument M; Itani D; Mack LA
    Eur J Surg Oncol; 2019 Apr; 45(4):699-703. PubMed ID: 30420189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROMIS Function Scores Are Lower in Patients Who Underwent More Aggressive Local Treatment for Desmoid Tumors.
    Newman ET; Lans J; Kim J; Ferrone M; Ready J; Schwab J; Raskin K; Calderon SL
    Clin Orthop Relat Res; 2020 Mar; 478(3):563-577. PubMed ID: 31429829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients.
    Bonvalot S; Eldweny H; Haddad V; Rimareix F; Missenard G; Oberlin O; Vanel D; Terrier P; Blay JY; Le Cesne A; Le Péchoux C
    Eur J Surg Oncol; 2008 Apr; 34(4):462-8. PubMed ID: 17709227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic Abdominal Wall Desmoid type Fibromatosis: treatment paradigm after thirty two years.
    Couto Netto SD; Teixeira F; Menegozzo CAM; Leão-Filho HM; Albertini A; Ferreira FO; Akaishi EH; Utiyama EM
    BMC Surg; 2018 Jun; 18(1):37. PubMed ID: 29879959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
    Colombo C; Miceli R; Lazar AJ; Perrone F; Pollock RE; Le Cesne A; Hartgrink HH; Cleton-Jansen AM; Domont J; Bovée JV; Bonvalot S; Lev D; Gronchi A
    Cancer; 2013 Oct; 119(20):3696-702. PubMed ID: 23913621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmoid tumors: need for an individualized approach.
    de Bree E; Keus R; Melissas J; Tsiftsis D; van Coevorden F
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):525-35. PubMed ID: 19374605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy.
    Ballo MT; Zagars GK; Pollack A; Pisters PW; Pollack RA
    J Clin Oncol; 1999 Jan; 17(1):158-67. PubMed ID: 10458229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors.
    Briand S; Barbier O; Biau D; Bertrand-Vasseur A; Larousserie F; Anract P; Gouin F
    J Bone Joint Surg Am; 2014 Apr; 96(8):631-8. PubMed ID: 24740659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance.
    van Houdt WJ; Husson O; Patel A; Jones RL; Smith MJF; Miah AB; Messiou C; Moskovic E; Al-Muderis O; Benson C; Zaidi S; Dunlop A; Strauss DC; Hayes AJ; van der Graaf WTA
    Ann Surg Oncol; 2019 Dec; 26(13):4699-4706. PubMed ID: 31531797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoid-Type Fibromatosis: Who, When, and How to Treat.
    Martínez Trufero J; Pajares Bernad I; Torres Ramón I; Hernando Cubero J; Pazo Cid R
    Curr Treat Options Oncol; 2017 May; 18(5):29. PubMed ID: 28439797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extra-abdominal desmoid fibromatosis--a sarcoma unit review of practice, long term recurrence rates and survival.
    Eastley N; Aujla R; Silk R; Richards CJ; McCulloch TA; Esler CP; Ashford RU
    Eur J Surg Oncol; 2014 Sep; 40(9):1125-30. PubMed ID: 24612653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis.
    van Broekhoven DL; Verhoef C; Elias SG; Witkamp AJ; van Gorp JM; van Geel BA; Wijrdeman HK; van Dalen T
    Br J Surg; 2013 Aug; 100(9):1214-9. PubMed ID: 23804156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation.
    Salas S; Dufresne A; Bui B; Blay JY; Terrier P; Ranchere-Vince D; Bonvalot S; Stoeckle E; Guillou L; Le Cesne A; Oberlin O; Brouste V; Coindre JM
    J Clin Oncol; 2011 Sep; 29(26):3553-8. PubMed ID: 21844500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoid-type fibromatosis of the head and neck in children: A changing situation.
    Paul A; Blouin MJ; Minard-Colin V; Galmiche L; Coulomb A; Corradini N; Boutroux H; Van den Abbeele T; Leboulanger N; Denoyelle F; Garabedian EN; Couloigner V; Orbach D
    Int J Pediatr Otorhinolaryngol; 2019 Aug; 123():33-37. PubMed ID: 31059930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.